Amphion Innovations PLC Directors' Dealings (0831L)
07 Enero 2016 - 1:00AM
UK Regulatory
TIDMAMP
RNS Number : 0831L
Amphion Innovations PLC
07 January 2016
Amphion Innovations plc
("Amphion" or "the Company")
Directors' Dealings
Directors Receive Shares in Lieu of Fees
London and New York, 7 January 2016 - Amphion Innovations plc
(AIM: AMP), the developer of medical, life science, and technology
businesses, announces that the Company has today issued 291,806
ordinary shares in the Company ("New Ordinary Shares"),
representing 0.15% of the enlarged issued share capital, to certain
of its Board members in lieu of their directors' fees for the
fourth quarter of 2015 and the first quarter of 2016, priced at
3.375 pence, being the average of the closing mid-market price for
the five days leading up to the market close on 31 December 2015.
Following this issue, the directors' shareholdings in the Company
are as follows:
Director Number of New Ordinary Shares Total Shareholding Percentage of voting rights
Miroslaw Izienicki 198,056 601,489 0.305%
Gerard Moufflet 93,750 1,273,958 0.645%
Admission of the 291,806 New Ordinary Shares, ranking pari passu
with the existing ordinary shares, to trading on AIM is expected on
12 January 2016. Following the issue and allotment of the New
Ordinary Shares, the total issued share capital of the Company will
increase to 197,511,229 ordinary shares with each share holding one
voting right.
For further information please contact:
Amphion Innovations
Charlie Morgan
+1 212 210 6224
Yellow Jersey PR
Charles Goodwin / Dominic Barretto
+44 (0)7747 788 221
Panmure Gordon Limited (Nominated Adviser and Corporate
Broker)
Freddy Crossley / Duncan Monteith (Corporate Finance)
Charlie Leigh-Pemberton (Corporate Broking)
+44 (0)20 7886 2500
Northland Capital Partners Limited (Joint Corporate Broker)
Patrick Claridge / David Hignell (Corporate Finance)
John Howes / Mark Treharne (Corporate Broking)
+44 (0)20 7382 1100
Plumtree Capital Limited (Financial Adviser)
Stephen Austin
+44 (0)20 7183 2493
+646 568 7502
About Amphion Innovations plc
Amphion Innovations is a developer of medical, life science and
technology businesses.
We use our extensive experience in company building to invest
and build shareholder value in high growth companies in the US and
UK. Amphion has significant shareholding in 7 Partner Companies
developing proven technologies targeting substantial commercial
marketplaces. The Amphion model has been refined to optimise the
commercialisation of patents and other intellectual property within
the Partner Companies. The Partner Companies collectively own or
control over 200 separately identified pieces of intellectual
property, a number which grows rapidly each year.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUGUCCGUPQPUQ
(END) Dow Jones Newswires
January 07, 2016 02:00 ET (07:00 GMT)
Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024